The Hamburg-based start-up Protembis GmbH has successfully closed a seven-digit seed financing round in order to fund R&D activities and clinical trials over the coming years. Protembis aims to develop, manufacture and commercialise an embolic protection device to be used during left heart procedures and vascular interventions. The ProtEmbo device is intended to protect patients from the risk of suffering a stroke during these procedures. In addition to the seed financing round, Protembis has secured a seven-digit state subsidy in co-operation with th Institute for Cardiovascular Engineering at RWTH University Aachen, which is granted by the Federal Ministry of Education and Research (BMBF). With the company’s locations in Hamburg and Aachen, opinion leaders, medical centres, funding and partner companies for product development, testing, feedback and commercialisation are easily accessible, which will enable Protembis to build a strong network of advisors and supporters for the development of its ProtEmbo device.
Dr. Gert Frank, CEO of Geratherm Medical AG, notes “The ProtEmbo device is clearly a novel and unique solution to address the danger of strokes in aortic valve replacement and other interventional heart procedures. Having closed this financing round Protembis will be able to reach the next level in terms of R&D and clinical trials. With Innovationsstarter Fonds Hamburg and the group of highly experienced angel investors we have an excellent setup to help further develop Protembis.”
Karl von Mangoldt and Conrad Rasmus, managing directors at Protembis GmbH, are pleased that the new investors provide a sound financing platform for the company’s future activities. They say: “This seed financing round allows us to achieve significant milestones in the development of our device and to obtain relevant clinical data.”
Along with the seed financing, Protembis has also strengthened its technical team. Oliver Schumacher, who has a wealth of experience with medical devices, will join the company as Chief Technology Officer.
source and further details: